维普中文期刊产品整合服务
412篇 您的检索式:作者名="Klimov"
    题名 作者 年代 出处 被引量
1Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma显示文摘AIM: To assess the safety and efficacy of trans-arterial chemo-embolization (TACE) in very elderly patients. METHODS: A prospective cohort study, from 2001 to 2010, compared clinical outcomes following TACE between patients ≥ 75 years old and younger patients (aged between 65 and 75 years and younger than 65 years) with hepatocellular carcinoma (HCC), diagnosed according to the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases criteria. The decision that patients were not candidates for curative therapy was made by a multidisciplinary HCC team. Data collected included demographics, co-morbidities, liver disease etiology, liver disease severity and the number of procedures. The primary outcome was mortality; secondary outcomes included post-embolization syndrome (nausea, fever, abdominal right upper quadrant pain, increase in liver enzymes with no evidence of sepsis and with a clinical course limited to 3-4 d post procedure) and 30-d complications. Additionally, changes in liver enzyme measurements were assessed [alanine and aspartate aminotransferase (ALT and AST), gamma-glutamyl transpeptidase and alkaline phosphatase] in the week following TACE. Analysis employed both univariate and multivariate methods (Cox regression models). RESULTS: Of 102 patients who underwent TACE as sole treatment, 10 patients (9.8%) were > 80 years old at diagnosis; 13 (12.7%) were between 75 and 80 years, 45 (44.1%) were between 65 and 75 years and 34 (33.3%) were younger than 65 years. Survival analysis demonstrated similar survival patterns between the elderly patients and younger patients. Age was also not associated with the adverse event rate. Survival rates at 1, 2 and 3 years from diagnosis were 74%, 37% and 31% among patients < 65 years; 83%, 66% and 48% among patients aged 65 to 75 years; and 86%, 41% and 23% among patients ≥ 75 years. There were no differences between the age groups in the pre-procedural care, including preventive treatment for contrast nephropathy and prophylactic antibiotics. Multivariate survival analysis, controlling for disease stage at diagnosis with the Barcelona Clinic Liver Cancer score, number of TACE procedures, sex and alphafetoprotein level at the time of diagnosis, found no significant difference in the mortality hazard for elderly vs younger patients, and there were no differences in post-procedural complications. Serum creatinine levels did not change after 55% of the procedures, in all age groups. In 42% of all procedures, serum creatinine levels increased by no more than 25% above the baseline levels prior to TACE. Overall, there were 69 post-embolization events (23%). Hepatocellular enzymes often increased following TACE, with no association with prognosis. In 40% of the procedures, ALT and AST levels rose by at least 100%. The increases in hepatocellular enzymes occurred similarly in all age groups. CONCLUSION: TACE is safe and effective in very elderly patients with HCC, and is not associated with decreased survival or increased complication rates.Matan J Cohen Allan I Bloom Orly Barak Alexander Klimov Tova Nesher Daniel Shouval Izhar Levi Oren Shibolet 2013World Journal of Gastroenterology2013,19,16:13
2Immune Response to Influenza Vaccine in Pediatric Patients With Inflammatory Bowel Disease显示文摘Petar Mamula Jonathan E. Markowitz David A. Piccoli Alexander Klimov Louis Cohen Robert N. Baldassano 2007Clinical Gastroenterology and Hepatology2007,,7:2
3Clonal structure of Yersinia pestis populations in experimental soil ecosystems显示文摘Breneva NV Maramovich AS Klimov VT 2007Zh Mikrobiol Epidemiol Immunobiol2007,,1:1
4Seawater pH sensor based on the long period grating in a single-mode-multimode-single-mode structure 显示文摘WANG Ke KLIMOV D KOLBER Z 2009Optical Engineering2009,48,3:1
5Elec- tro-plasticity of metals显示文摘KLIMOV K M SHNYREV G D NOVIKOV I I 1974Doklady Akademii Nauk SSSR1974,219,2:1
6Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses显示文摘Li S Liu C Klimov A 1999J Infect Dis1999,179,5:1
7A new class of Invertible mappings 显示文摘KLIMOV A SHAMIR A 2002LNCS2002,,2523:1
8Theory of the Shim- my Phenomenon显示文摘Ph Zhuravlev V Klimov D M 2010Mechanical of Solids2010,45,3:1
9Neuraminidase inhibitor sus- ceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir显示文摘Wang D Sleeman K Huang W Nguyen H T LevineM Cheng Y Li X Tan M Xing X Xu X Klimov A I Gubareva L V Shu Y 2013Antiviral Research2013,97,3:1
10Relativistic X band BWO with 3-GW output power显示文摘C-unin A V Klimov A I Korovin S D 1998IEEE Trans on Plasma Sci1998,26,3:1
11Modified M2 proteins produce heterotypic immunity against influenza A virus显示文摘Frace A M Klimov A I Rowe T 1999Vaccine1999,17,:1
12A vircator with electron beam premodulation based on high current repetitively pulsed accel-erator显示文摘Kitsanov S A Klimov A I Korovin S D 2002IEEE Trans Plas Sci2002,30,1:1
13Surveillance and impact of influenza in the United States显示文摘Klimov A Simonsen L Fukuda K 1999Vaccine1999,,:1
14Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion proteln显示文摘TRIANA-BALTZER G B GUBAREVA L V KLIMOV A I 2009PLoS One2009,4,11:1
15Measurement of parameters of X-band high-power microwave superradiative pulses显示文摘Klimov A I Kovalchuk O B Rostov V V 2008IEEE Trans on Plasma Sci2008,36,3:1
16Modified M2 proteins produce heterotypic immunity against influenza A virus显示文摘Frace A M Klimov A I Rowe T 1999Vaccine1999,17,18:1
17Chemical mechanical planarization of copper: role of oxidants and inhibitors 显示文摘Deshpande S Kuiry S C Klimov M 2004Journal of the Electrochemical Society2004,151,:1
18Co-Mo catalysts for ultra-deep HDS of diesel fuels prepared via synthesis of bimetallic surface compounds 显示文摘KLIMOV O V PASHIGREVA A V FEDOTOV M A 2010Journal of Molecular Catalysis A: Chemical2010,322,12:1
19Innovative nuclear technology based on modular multi-purpose lead–bismuth cooled fast reactors显示文摘A.V. Zrodnikov G.I. Toshinsky O.G. Komlev Yu.G. Dragunov V.S. Stepanov N.N. Klimov V.N. Generalov I.I. Kopytov V.N. Krushelnitsky 2007Progress in Nuclear Energy2007,,2:1
20Mutually unbiased bases and generalized Bell states显示文摘Klimov A B Syeh D Sanchez-Soto L L 2009Phys Rev A2009,79,05:1
返回顶部 每页显示:
共21页 首页 上一页 第1页 下一页 末页 /21 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费